Scientific publishing, research assessment, and responsible research

Versión para impresiónVersión PDF
Dr. Michele Garfinkel
European Molecular Biology Organisation
Miércoles, 11 Marzo 2015 - 12:00

Scientific publishing and the ways scientists use the scientific literature are changing almost on a daily basis. Obvious examples of this are the move away from print publication, and the move toward open access. But other changes in publishing are occurring as a result of the development of new ideas in science governance; in turn, some of these changes alter the way scientists and administrators look at governance. In this talk, I will review some of these developments particularly with respect to research assessment, responsible conduct of research, and the value of transparency in science. I will use some examples directly from the journals of the EMBO Press and will include a more general discussion about immediate policy concerns. 

Lugar: 

Ciudad Politécnica de la Innovación
Edificio 8E, Acceso J, Planta 4ª (Sala Descubre. Cubo Rojo)
Universidad Politécnica de Valencia | Camino de Vera s/n

Breve CV del Ponente: 

Michele Garfinkel is the Manager of the Science Policy Programme at the European Molecular Biology Organization in Heidelberg, Germany. She is responsible for policy research concentrated on issues in emerging technologies, scientific publishing, and the sharing of benefits of research and discovery. The Policy Programme also addresses subjects of concern to scientists and policymakers, including research funding and responsible conduct of research. 

Until March 2011 she was a policy analyst at the J. Craig Venter Institute. Her research focused on identifying emerging societal concerns associated with emerging genomic technologies. 

Michele graduated in Genetics from the University of California, Berkeley and obtained her Ph.D. in Microbiology from the University of Washington, Seattle. She also holds an M.A. in Science, Technology, and Public Policy from the George Washington University. She was a post-doctoral fellow at the Fred Hutchinson Cancer Research Center in Seattle and a research fellow at Columbia University in New York.